N-(2,3-Dihydro-1H-inden-5-yl)-4-methylpyrrolidin-2-imine Hydrochloride

ID: ALA3408295

Chembl Id: CHEMBL3408295

PubChem CID: 89964736

Max Phase: Preclinical

Molecular Formula: C14H19ClN2

Molecular Weight: 214.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CN/C(=N\c2ccc3c(c2)CCC3)C1.Cl

Standard InChI:  InChI=1S/C14H18N2.ClH/c1-10-7-14(15-9-10)16-13-6-5-11-3-2-4-12(11)8-13;/h5-6,8,10H,2-4,7,9H2,1H3,(H,15,16);1H

Standard InChI Key:  QJIXIZZLHVPLNG-UHFFFAOYSA-N

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nisch Nischarin (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 214.31Molecular Weight (Monoisotopic): 214.1470AlogP: 2.83#Rotatable Bonds: 1
Polar Surface Area: 24.39Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.25CX LogP: 2.97CX LogD: 1.22
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.76Np Likeness Score: -0.40

References

1. Gasparik V, Greney H, Schann S, Feldman J, Fellmann L, Ehrhardt JD, Bousquet P..  (2015)  Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.,  58  (2): [PMID:25521963] [10.1021/jm501456p]

Source